Patient Access Schemes

Patient access schemes (PAS) are innovative pricing agreements, proposed by pharmaceutical companies, designed to improve cost effectiveness and facilitate patient access to specific drugs or other technologies. The table below shows treatments recommended by NICE through NICE technology appraisals, alongside their approved PAS and other commercial arrangements, for use in the NHS.

Abbreviations: TA=technology appraisal; HST=highly specialised technologies; PAS=patient access scheme; CAA=commercial access agreement